Sheila M Manemann1, David S Knopman2, Jennifer St Sauver1, Suzette J Bielinski1, Alanna M Chamberlain1,3, Susan A Weston1, Ruoxiang Jiang1, Véronique L Roger3,4. 1. Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. 2. Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA. 3. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. 4. Epidemiology and Community Health Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
BACKGROUND: Cognitive function is essential to effective self-management of heart failure (HF). Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) can coexist with HF, but its exact prevalence and impact on health care utilization and death are not well defined. METHODS: Residents from 7 southeast Minnesota counties with a first-ever diagnosis code for HF between January 1, 2013 and December 31, 2018 were identified. Clinically diagnosed AD/ADRD was ascertained using the Centers for Medicare and Medicaid (CMS) Chronic Conditions Data Warehouse algorithm. Patients were followed through March 31, 2020. Cox and Andersen-Gill models were used to examine associations between AD/ADRD (before and after HF) and death and hospitalizations, respectively. RESULTS: Among 6336 patients with HF (mean age [SD] 75 years [14], 48% female), 644 (10%) carried a diagnosis of AD/ADRD at index HF diagnosis. The 3-year cumulative incidence of AD/ADRD after HF diagnosis was 17%. During follow-up (mean [SD] 3.2 [1.9] years), 2618 deaths and 15,475 hospitalizations occurred. After adjustment, patients with AD/ADRD before HF had nearly a 2.7 times increased risk of death, but no increased risk of hospitalization compared to those without AD/ADRD. When AD/ADRD was diagnosed after the index HF date, patients experienced a 3.7 times increased risk of death and a 73% increased risk of hospitalization compared to those who remain free of AD/ADRD. CONCLUSIONS: In a large, community cohort of patients with incident HF, the burden of AD/ADRD is quite high as more than one-fourth of patients with HF received a diagnosis of AD/ADRD either before or after HF diagnosis. AD/ADRD markedly increases the risk of adverse outcomes in HF underscoring the need for future studies focused on holistic approaches to improve outcomes.
BACKGROUND: Cognitive function is essential to effective self-management of heart failure (HF). Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) can coexist with HF, but its exact prevalence and impact on health care utilization and death are not well defined. METHODS: Residents from 7 southeast Minnesota counties with a first-ever diagnosis code for HF between January 1, 2013 and December 31, 2018 were identified. Clinically diagnosed AD/ADRD was ascertained using the Centers for Medicare and Medicaid (CMS) Chronic Conditions Data Warehouse algorithm. Patients were followed through March 31, 2020. Cox and Andersen-Gill models were used to examine associations between AD/ADRD (before and after HF) and death and hospitalizations, respectively. RESULTS: Among 6336 patients with HF (mean age [SD] 75 years [14], 48% female), 644 (10%) carried a diagnosis of AD/ADRD at index HF diagnosis. The 3-year cumulative incidence of AD/ADRD after HF diagnosis was 17%. During follow-up (mean [SD] 3.2 [1.9] years), 2618 deaths and 15,475 hospitalizations occurred. After adjustment, patients with AD/ADRD before HF had nearly a 2.7 times increased risk of death, but no increased risk of hospitalization compared to those without AD/ADRD. When AD/ADRD was diagnosed after the index HF date, patients experienced a 3.7 times increased risk of death and a 73% increased risk of hospitalization compared to those who remain free of AD/ADRD. CONCLUSIONS: In a large, community cohort of patients with incident HF, the burden of AD/ADRD is quite high as more than one-fourth of patients with HF received a diagnosis of AD/ADRD either before or after HF diagnosis. AD/ADRD markedly increases the risk of adverse outcomes in HF underscoring the need for future studies focused on holistic approaches to improve outcomes.
Authors: Geoffrey H Tison; Alanna M Chamberlain; Mark J Pletcher; Shannon M Dunlay; Susan A Weston; Jill M Killian; Jeffrey E Olgin; Véronique L Roger Journal: Int J Med Inform Date: 2018-09-19 Impact factor: 4.046
Authors: Angela L Jefferson; Jayandra J Himali; Alexa S Beiser; Rhoda Au; Joseph M Massaro; Sudha Seshadri; Philimon Gona; Carol J Salton; Charles DeCarli; Christopher J O'Donnell; Emelia J Benjamin; Philip A Wolf; Warren J Manning Journal: Circulation Date: 2010-08-02 Impact factor: 29.690
Authors: Rebecca F Gottesman; Marilyn S Albert; Alvaro Alonso; Laura H Coker; Josef Coresh; Sonia M Davis; Jennifer A Deal; Guy M McKhann; Thomas H Mosley; A Richey Sharrett; Andrea L C Schneider; B Gwen Windham; Lisa M Wruck; David S Knopman Journal: JAMA Neurol Date: 2017-10-01 Impact factor: 18.302
Authors: David S Knopman; Ronald C Petersen; Walter A Rocca; Eric B Larson; Mary Ganguli Journal: Alzheimers Dement Date: 2011-01 Impact factor: 21.566
Authors: Alanna M Chamberlain; Shannon M Dunlay; Yariv Gerber; Sheila M Manemann; Ruoxiang Jiang; Susan A Weston; Véronique L Roger Journal: Mayo Clin Proc Date: 2017-02 Impact factor: 7.616
Authors: Sheila M Manemann; Alanna M Chamberlain; Véronique L Roger; Cynthia Boyd; Andrea Cheville; Shannon M Dunlay; Susan A Weston; Ruoxiang Jiang; Lila J Finney Rutten Journal: J Am Geriatr Soc Date: 2018-03-30 Impact factor: 5.562
Authors: Janaka Lovell; Tony Pham; Samer Q Noaman; Marie-Claire Davis; Marilyn Johnson; Joseph E Ibrahim Journal: BMC Cardiovasc Disord Date: 2019-04-29 Impact factor: 2.298
Authors: Jan Traub; Markus Otto; Roxane Sell; Dennis Göpfert; György Homola; Petra Steinacker; Patrick Oeckl; Caroline Morbach; Stefan Frantz; Mirko Pham; Stefan Störk; Guido Stoll; Anna Frey Journal: Alzheimers Res Ther Date: 2022-10-10 Impact factor: 8.823